Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5842682 | Life Sciences | 2012 | 10 Pages |
Abstract
Taken together, these findings provide novel lines of evidence that sortilin governs the toxic action of extracellular AβOs, which affects the degradation and/or clearance of either intraneuronal AβOs or tau. Thus, therapeutic intervention targeting extracellular AβOs themselves or for preventing the interaction between intraneuronal AβOs and tau is a promising strategy to be developed for AD treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ayumi Takamura, Yota Sato, Daisuke Watabe, Yasuhide Okamoto, Takashi Nakata, Takeshi Kawarabayashi, Salvatore Oddo, Frank M. LaFerla, Mikio Shoji, Etsuro Matsubara,